100 Participants Needed

Web-based Sleep Interventions for Caregiver Insomnia

(NiteCAPP Trial)

Recruiting at 1 trial location
CS
Overseen ByChristina S McCrae
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri-Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this project evaluate the efficacy of NiteCAPP in improving insomnia in a rural dementia caregiver sample (n of 100 caregiver and PWD dyads). We will measure both the short term (post-treatment) and long term (6 and 12 months) effects of the intervention on CG sleep, arousal, inflammation, health, mood, burden and cognitive function, and PWD sleep.

Will I have to stop taking my current medications?

If you are taking sleep medications, you must have been off them for at least one month or have been on a stable dose for six months to participate. Other medications that affect sleep, like certain psychotropic drugs or beta-blockers, may also need to be stopped.

What data supports the effectiveness of the treatment NiteCAPP CARE, NiteCAPP CARES, NiteCAPP SHARES, and similar treatments for caregiver insomnia?

Research shows that online cognitive behavioral therapy for insomnia (CBT-i) can improve sleep efficiency and reduce insomnia severity. Digital health technologies, like smartphone apps, have been effective in delivering these therapies remotely, making them accessible and engaging for users.12345

Is the web-based sleep intervention NiteCAPP safe for humans?

The research does not provide specific safety data for NiteCAPP, but web-based cognitive behavioral therapy for insomnia (CBT-I) is generally considered safe for humans, as it is a non-invasive treatment focusing on improving sleep habits and behaviors.23467

What makes the NiteCAPP treatment unique for caregiver insomnia?

NiteCAPP is a web-based cognitive behavioral therapy for insomnia (CBT-I) that offers a convenient and scalable way to deliver therapy to caregivers experiencing insomnia, making it accessible to a large number of people at a lower cost compared to traditional in-person therapy.12489

Research Team

CS

Christina S McCrae

Principal Investigator

University of South Florida

Eligibility Criteria

This trial is for adult caregivers living with someone who has dementia and insomnia. Caregivers must have their own insomnia diagnosis, not be on recent sleep meds, and read English. The person with dementia must also suffer from insomnia but can't be on new sleep meds or have untreated sleep disorders like severe apnea.

Inclusion Criteria

I have had trouble sleeping for over 6 months, affecting my daily life.
PWD Eligibility: 1. probable/possible Alzheimer's Disease (self-report or primary care provider written confirmation), 2. experiencing 1+ problem on Nighttime Behavior Inventory 3+ nights per week, 3. able to tolerate actigraphy, 4. not taking sleep medications for 1+ month or stabilized for 6+ months, 5. untreated sleep disorder for which Cognitive Behavioral Therapy for Insomnia (CBT-I) is not recommended (e.g., apnea), 6. scoring <32 on Sleep Apnea scale, Sleep Disorders Questionnaire

Exclusion Criteria

CG Exclusion criteria: 1. unable to consent, 2. cognitive impairment (Telephone Interview for Cognitive Status (TICS) score <25), 3. sleep disorder other than insomnia (e.g., apnea with apnea/hypopnea index-AHI >15), 4. bipolar or seizure disorder, 5. other major psychopathology except depression or anxiety (e.g., suicidal, psychotic), 6. severe untreated psychiatric comorbidity, 7. taking psychotropic or other medications (e.g., beta-blockers) that alter sleep, 8. receiving non-pharmacological treatment for sleep or mood outside current trial.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the NiteCAPP web-based intervention, which includes 4 weekly sessions and 4 bimonthly booster sessions.

8 weeks
Sessions completed individually online

Follow-up

Participants are monitored for long-term effects on sleep, arousal, inflammation, health, mood, burden, and cognitive function.

12 months
Assessments at 6 and 12 months

Treatment Details

Interventions

  • NiteCAPP CARE
  • NiteCAPP CARES
  • NiteCAPP SHARE
  • NiteCAPP SHARES
Trial Overview The NiteCAPP study tests two web-based programs (CARES & SHARES) designed to help rural caregivers of dementia patients manage insomnia. It looks at how well these programs work right after treatment and checks again after 6 and 12 months for any changes in the caregiver's sleep, health, mood, stress levels, and cognitive function.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: NiteCAPP SHARESExperimental Treatment1 Intervention
Sleep Hygiene and Related Education. Web-based intervention that will include 4 weekly sessions and 4 bimonthly boosters. Each session is to be completed individually by CG (with PWD to extent able) in a single sitting (less than 45 mins). Each session should be completed in 7 days with next session released only after prior one completed. Session 1 focuses on expanded sleep education and sleep hygiene. Session 2 focuses insomnia education and sleep hygiene support. Session 3 focuses on targeted sleep education and sleep in dementia. Session 4 focuses on a review of skills and plan for maintenance of behavior change. Boosters review skills, encourage practice, and troubleshoot issues.
Group II: NiteCAPP CARESExperimental Treatment1 Intervention
Cognitive Behavioral Treatment-Insomnia. Web-based intervention that will include 4 weekly sessions and 4 bimonthly boosters. Each session is to be completed individually by CG (with PWD to extent able) in a single sitting (less than 45 mins). Each session should be completed in 7 days with next session released only after prior one completed. Session 1 focuses on sleep education, sleep hygiene, and stimulus control. Session 2 focuses on sleep compression, relaxation, and problem solving. Session 3 focuses on coping and stress management and cognitive therapy. Session 4 focuses on a review of skills and plan for maintenance of behavior change.

NiteCAPP CARE is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as NiteCAPP CARES for:
  • Insomnia in rural dementia caregivers

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri-Columbia

Lead Sponsor

Trials
387
Recruited
629,000+

University of South Florida

Lead Sponsor

Trials
433
Recruited
198,000+

Findings from Research

A study involving 75 participants with insomnia disorder showed that an interactive online cognitive behavioral therapy (CBT-i) significantly improved sleep efficiency and sleep latency, indicating its efficacy as a treatment option.
Rigorous screening revealed that 62% of those who accessed the therapy had other sleep disorders, highlighting the importance of proper assessment before starting treatment to ensure effective outcomes.
A pilot evaluation of an online cognitive behavioral therapy for insomnia disorder - targeted screening and interactive Web design lead to improved sleep in a community population.Anderson, KN., Goldsmith, P., Gardiner, A.[2021]
The Nitra application, an internet-based cognitive behavioral therapy for insomnia (CBT-i), significantly improved sleep efficiency and various sleep parameters in 40 adults with chronic subthreshold to moderate insomnia over a 4-week intervention period.
Participants who adhered closely to the recommended sleep schedule showed a higher likelihood of achieving normal sleep efficiency, highlighting the importance of consistent sleep habits in managing insomnia.
Effectiveness of internet-based CBT-I for the treatment of chronic subthreshold to moderate insomnia.Theppornpitak, W., Hemrungrojn, S., Thienwiwatnukul, K., et al.[2023]
Before the release of the CBT-I Coach app, 87% of VA-trained clinicians believed it could improve insomnia treatment and intended to use it, indicating strong initial support for the app's potential benefits.
Two years post-release, nearly 60% of clinicians reported using the app with patients, noting positive effects on homework adherence and treatment outcomes, suggesting that the app effectively supports cognitive behavioral therapy for insomnia.
CBT-I Coach: A Description and Clinician Perceptions of a Mobile App for Cognitive Behavioral Therapy for Insomnia.Kuhn, E., Weiss, BJ., Taylor, KL., et al.[2018]

References

A pilot evaluation of an online cognitive behavioral therapy for insomnia disorder - targeted screening and interactive Web design lead to improved sleep in a community population. [2021]
Effectiveness of internet-based CBT-I for the treatment of chronic subthreshold to moderate insomnia. [2023]
CBT-I Coach: A Description and Clinician Perceptions of a Mobile App for Cognitive Behavioral Therapy for Insomnia. [2018]
Clinician Perceptions Related to the Use of the CBT-I Coach Mobile App. [2022]
Efficacy of a Smartphone-Based Virtual Companion to Treat Insomniac Complaints in the General Population: Sleep Diary Monitoring Versus an Internet Autonomous Intervention. [2023]
Development and Initial Evaluation of Web-Based Cognitive Behavioral Therapy for Insomnia in Rural Family Caregivers of People With Dementia (NiteCAPP): Mixed Methods Study. [2023]
Mobile App Use for Insomnia Self-Management: Pilot Findings on Sleep Outcomes in Veterans. [2020]
Developing and Testing a Web-Based Provider Training for Cognitive Behavioral Therapy of Insomnia. [2021]
Patient perspectives on facilitators and barriers to equitable engagement with digital CBT-I. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity